Notably, GPNMB, a critical regulator of microglial activation and neuroinflammation, has been demonstrated to stimulate the production of pro-inflammatory cytokines, thus contributing to the inflammatory cascade observed in AD [111-114]. This evidence concerns the gene GPNMB and Alzheimer disease.